427 related articles for article (PubMed ID: 31563998)
41. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
Kottmann RM; Trawick E; Judge JL; Wahl LA; Epa AP; Owens KM; Thatcher TH; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1305-12. PubMed ID: 26408551
[TBL] [Abstract][Full Text] [Related]
42. New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma.
Abraham DJ; Eckes B; Rajkumar V; Krieg T
Curr Rheumatol Rep; 2007 May; 9(2):136-43. PubMed ID: 17502044
[TBL] [Abstract][Full Text] [Related]
43. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
Gleitz HF; Kramann R; Schneider RK
J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
[TBL] [Abstract][Full Text] [Related]
44. Diverse origins and activation of fibroblasts in cardiac fibrosis.
Aujla PK; Kassiri Z
Cell Signal; 2021 Feb; 78():109869. PubMed ID: 33278559
[TBL] [Abstract][Full Text] [Related]
45. Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair.
Navas A; Magaña-Guerrero FS; Domínguez-López A; Chávez-García C; Partido G; Graue-Hernández EO; Sánchez-García FJ; Garfias Y
Stem Cells Transl Med; 2018 Dec; 7(12):906-917. PubMed ID: 30260581
[TBL] [Abstract][Full Text] [Related]
46. Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.
Avery D; Govindaraju P; Jacob M; Todd L; Monslow J; Puré E
Matrix Biol; 2018 Apr; 67():90-106. PubMed ID: 29248556
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
48. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
49. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
Kuehl T; Lagares D
Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
[TBL] [Abstract][Full Text] [Related]
50. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming.
Merkt W; Zhou Y; Han H; Lagares D
Wound Repair Regen; 2021 Jul; 29(4):678-691. PubMed ID: 34117675
[TBL] [Abstract][Full Text] [Related]
51. Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation.
Yuan Q; Tan RJ; Liu Y
Adv Exp Med Biol; 2019; 1165():253-283. PubMed ID: 31399969
[TBL] [Abstract][Full Text] [Related]
52. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
53. Control of Myofibroblast Differentiation and Function by Cytoskeletal Signaling.
Sandbo N; Smolyaninova LV; Orlov SN; Dulin NO
Biochemistry (Mosc); 2016 Dec; 81(13):1698-1708. PubMed ID: 28260491
[TBL] [Abstract][Full Text] [Related]
54. Cellular and molecular mechanisms of intestinal fibrosis.
Speca S; Giusti I; Rieder F; Latella G
World J Gastroenterol; 2012 Jul; 18(28):3635-61. PubMed ID: 22851857
[TBL] [Abstract][Full Text] [Related]
55. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
56. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction.
Hara A; Kobayashi H; Asai N; Saito S; Higuchi T; Kato K; Okumura T; Bando YK; Takefuji M; Mizutani Y; Miyai Y; Saito S; Maruyama S; Maeda K; Ouchi N; Nagasaka A; Miyata T; Mii S; Kioka N; Worthley DL; Murohara T; Takahashi M; Enomoto A
Circ Res; 2019 Aug; 125(4):414-430. PubMed ID: 31221024
[TBL] [Abstract][Full Text] [Related]
57. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies.
Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T
Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196
[TBL] [Abstract][Full Text] [Related]
58. Tannic acid modulates fibroblast proliferation and differentiation in response to pro-fibrotic stimuli.
Pattarayan D; Sivanantham A; Bethunaickan R; Palanichamy R; Rajasekaran S
J Cell Biochem; 2018 Aug; 119(8):6732-6742. PubMed ID: 29665059
[TBL] [Abstract][Full Text] [Related]
59. MiR-124 regulates transforming growth factor-β1 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt/β-catenin signaling.
Lu Y; Zhang T; Shan S; Wang S; Bian W; Ren T; Yang D
Dev Biol; 2019 May; 449(2):115-121. PubMed ID: 30802451
[TBL] [Abstract][Full Text] [Related]
60. Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis.
Dolivo DM; Larson SA; Dominko T
Cell Mol Life Sci; 2018 Oct; 75(20):3663-3681. PubMed ID: 30027295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
